Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Bonn

Headquarters: Bonn, Germany
Year Founded: 1818
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jul 31, 2020
Distillery Therapeutics

ADORA2B agonism for obesity and aging-induced sarcopenia

BioCentury | Jan 31, 2020
Distillery Therapeutics

Inhibiting SPK2 to treat Middle East respiratory syndrome

BioCentury | Jul 20, 2018
Financial News

IFM launches subsidiary with $31M series A

BioCentury | Jul 19, 2018
Financial News

IFM launches subsidiary with $31M series A

BioCentury | Feb 21, 2018
Distillery Techniques

Drug delivery

BioCentury | Jan 19, 2018
Strategy

After amyloid

How the Alzheimer’s disease community is moving past amyloid
BioCentury | Jan 4, 2018
Distillery Therapeutics

Neurology

BioCentury | Dec 22, 2017
Preclinical News

New inflammasome target for early intervention in AD

BioCentury | Nov 15, 2017
Distillery Therapeutics

Cancer

Items per page:
1 - 10 of 67